Hello, welcome to the annual meeting of stockholders of Camp4 Therapeutics Corporation. Please note that today's meeting is being recorded. It is now my pleasure to turn today's meeting over to Josh Mandel-Brehm, President, Chief Executive Officer, and Director of Camp4 Therapeutics Corporation. Mr. Mandel-Brehm, the floor is yours.
Thank you. Good morning, ladies and gentlemen, welcome to the 2026 annual meeting of stockholders of Camp4 Therapeutics Corporation. I'm Josh Mandel-Brehm, President, Chief Executive Officer, and Director of Camp4, and at the direction of the Chair of the Board of Directors, I will be presiding over this meeting. At this time, I call the meeting to order. We are holding our annual meeting in an all-virtual format and are pleased to have everyone join this live webcast. We've designed this meeting to provide stockholders the same rights and opportunities to participate as they would in an in-person meeting. Before we get to formal business of the meeting, I would like to make some introductions. Joining us at the meeting today are the following additional members of the Board of Directors: Douglas Williams, Steven Holtzman, Michael MacLean, Andrew Schwab, Murray Stewart, and Richard Young.
Also joining us are Kelly Gold, Camp4's Chief Financial Officer and Treasurer, and Todd Rosenthal, Camp4's VP, Corporate and Legal Affairs and Corporate Secretary. I'd also like to introduce Zach Parker, a representative of Ernst & Young LLP, our independent registered public accounting firm, and David Dixon, who has been appointed to act as Inspector of Election. Stockholders will have the opportunity to submit questions during the meeting using the virtual meeting platform. The meeting is not to be used as a forum to present personal matters or general economic, political, or other views that are not directly related to our business and the matters properly before the meeting. Therefore, questions on such matters will not be answered.
Please note that various remarks we make about future expectations, plans, and prospects for Camp4 constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the Risk Factors section of our annual report on Form 10-K and quarterly reports on Form 10-Q, which are all on file with the SEC. In addition, these forward-looking statements represent our expectations only as of today. While we may elect to update these forward-looking statements, we specifically disclaim any obligation to do so. Any forward-looking statements should not be relied upon as representing our views as of any future date.
I have received an affidavit from Broadridge Financial Solutions certifying that the notice of the annual meeting and proxy statement were sent to all stockholders of record as of April 13th, 2026, a copy of which will be included in the minutes of the meeting. Our first order of business at this meeting is to determine whether the shares represented at this meeting, either in person, via this virtual meeting, or by proxy, are sufficient to constitute a quorum for the purposes of transacting business. Holders of 51,925,800 shares of common stock are entitled to vote at this meeting. The Inspector of Election has informed me that there are present at this meeting, either in person, via this virtual meeting, or by proxy, a total of 39,998,634 shares of common stock, or approximately 77% of all shares entitled to vote at this meeting.
I hereby declare that a quorum exists. Turning now to the items to be voted on at this meeting, as indicated in the notice of meeting and accompanying documents that were sent to stockholders, the first matter to be voted on is the election of three Class II directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified. The three nominees for election are Steven Holtzman, Murray Stewart, and Richard Young. The second matter to be voted on is the ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31st, 2026. The third matter to be voted on is the approval of an amendment to Camp4 Therapeutics Corporation 2024 Equity Incentive Plan.
If there are any questions on the proposals, they may be submitted on the virtual meeting website. I remind you that there will be an opportunity for general questions about our business, not related to the proposals, after the formal portion of the meeting has concluded. If asking a question, please also include your name and affiliation to the company. Seeing no questions, we'll move on to voting on the proposal. I hereby declare the polls are now open for each matter to be voted upon today. If you previously voted by proxy, whether by mail, telephone, or internet, you should not vote by ballot unless you wish to change your vote. Your submission of a ballot will revoke all proxies. The persons named in the proxy will vote your shares as indicated on the proxy you provided.
If you have not yet voted or if you previously voted by proxy and wish to change your vote, you may vote by following the instructions on the virtual meeting website. We will pause briefly to allow stockholders to vote. The polls are now closed. Will Mr. Dixon please tabulate the votes? We now have the preliminary report of the results of the meeting. Each of the nominees for director has been elected as a Class II director. The appointment of Ernst & Young LLP has been ratified. The amendment of the Camp4 Therapeutics Corporation 2024 Equity Incentive Plan has been approved. The final vote results will be included in the Form 8-K that will be filed within four business days after this meeting. There is no further business to come before the meeting. I declare the formal part of this meeting adjourned.
We will now answer appropriate questions from the stockholders. Please follow the instructions provided on the virtual meeting website to submit questions. This concludes the meeting. You may now disconnect.